Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shifting the Timeline of Esophageal Adenocarcinoma: The Interplay of Lifestyle, Comedication, and Genetics.

United European gastroenterology journal·2026
Same author

Vancomycin Exposure Dynamics and Clinical Outcomes in Critically Ill Patients: A Retrospective Cohort Study.

Antibiotics (Basel, Switzerland)·2026
Same author

SARS-CoV-2 infection, viral burden, and variant-specific outcomes in hospitalized patients with heart failure.

European journal of internal medicine·2026
Same author

Targeting SMYD2 improves immunotherapy response in experimental hepatocellular carcinoma.

Molecular therapy. Oncology·2026
Same author

Are CD4<sup>+</sup> T-Cell Counts Associated with <i>Pneumocystis jirovecii</i> Detection in Hospitalized Patients with Liver Disease? A Retrospective Exploratory Pilot Analysis.

Livers·2026
Same author

Hepatic Steatosis: A Pandemic Disease Causing Serious Secondary Diseases.

Deutsches Arzteblatt international·2026

Related Experiment Video

Updated: Jun 27, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Systematic assessment for potential endogenous normalizers for microRNA analysis in fecal samples.

Theresa Lederer1, Konrad Lehr2, Cosima Thon1

  • 1Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University, Leipziger Str. 44, 39104, Magdeburg, Germany.

Scientific Reports
|June 25, 2026
PubMed
Summary
This summary is machine-generated.

Researchers identified miR-638 as a stable endogenous normalizer for microRNA (miRNA) analysis in fecal samples. This finding is crucial for accurate biomarker detection in inflammatory and neoplastic diseases.

More Related Videos

Fecal (micro) RNA Isolation
05:35

Fecal (micro) RNA Isolation

Published on: October 28, 2020

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

Related Experiment Videos

Last Updated: Jun 27, 2026

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
08:12

Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer

Published on: March 14, 2019

Fecal (micro) RNA Isolation
05:35

Fecal (micro) RNA Isolation

Published on: October 28, 2020

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genomics

Background:

  • MicroRNAs (miRNAs) show potential as biomarkers for various diseases in fecal samples.
  • Current fecal miRNA analysis lacks standardized normalization methods, hindering reliable biomarker discovery.
  • Existing normalization strategies are insufficient for the complexities of fecal sample analysis.

Purpose of the Study:

  • To identify and validate a stable endogenous normalizer for microRNA (miRNA) analysis in human fecal samples.
  • To address the lack of consensus on normalization techniques for fecal miRNA biomarker studies.
  • To find a reliable miRNA that is unaffected by sample collection or processing variables.

Main Methods:

  • Multi-step study involving three independent cohorts of healthy subjects and patients with inflammatory bowel disease (IBD) and liver disease.
  • MiRNA profiling using serial dilutions of blood and fecal samples.
  • Analysis via Affymetrix GeneChip microarray technology and validation with TaqMan quantitative real-time PCR (qPCR).

Main Results:

  • Five stable miRNAs were identified in fecal samples; miR-638 demonstrated exceptional stability (Log2FC of 0.0004).
  • miR-638 stability was confirmed across independent cohorts of IBD and liver disease patients.
  • No significant influence of age or other factors on fecal miR-638 levels was observed.

Conclusions:

  • miR-638 is a highly stable and suitable endogenous normalizer for fecal miRNA analysis.
  • Its stability and high concentration in feces offer advantages over previously used normalizers like miR-16.
  • This finding supports the development of more accurate miRNA-based diagnostic tools for gastrointestinal and liver diseases.